Abstract
Background: We performed large genomic rearrangement (LGR) analysis of BRCA1/2 in ovarian cancer patients who were negative for BRCA1/2 as a result of the Next Generation Sequencing (NGS) analysis to determine the prevalence and the characteristics of the mutations.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
